Website Header with Language Selector and Dropdowns

N-Nitroso Trandolapril Impurity A


Catalog Number: CL-TDA-NO-03
CAS No.: NA
Mol.F: C23H31N3O6
Mol.W: 445.52
Inv. Status: Custom Synthesis

Chemical Name: (2S,3aR,7aS)-1-(N-((S)-1-methoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydro-1H-indole-2-carboxylic acid .

Country of Origin: India

Product Category: Trandolapril Impurities


N-Nitroso Trandolapril Impurity A is identified by CAS No. NA and is chemically known as (2S,3aR,7aS)-1-(N-((S)-1-methoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydro-1H-indole-2-carboxylic acid .

N-Nitroso Trandolapril Impurity A is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Trandolapril.

Page Keywords: Buy N-Nitroso Trandolapril Impurity A | Purchase N-Nitroso Trandolapril Impurity A | N-Nitroso Trandolapril Impurity A suppliers | N-Nitroso Trandolapril Impurity A manufacturers | N-Nitroso Trandolapril Impurity A price | N-Nitroso Trandolapril Impurity A Importer | N-Nitroso Trandolapril Impurity A Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-TDA-NO-02
CAS No: NA
Mol Wt: 459.54
Mol F: C24H33N3O6
Inv. Status: Custom Synthesis
CAT No: CL-TDA-NO-01
CAS No: NA
Mol Wt: 459.54
Mol F:  C24H33N3O6
Inv. Status: Custom Synthesis
CAT No: CL-TDA-NO-08
CAS No: NA
Mol Wt: 288.35
Mol F: C16H20N2O3
Inv. Status: Custom Synthesis
CAT No: CL-TDA-NO-04
CAS No: NA
Mol Wt: 473.57
Mol F: C25H35N3O6
Inv. Status: Custom Synthesis
CAT No: CL-TDA-NO-05
CAS No: NA
Mol Wt: 473.57
Mol F: C25H35N3O6
Inv. Status: Custom Synthesis
CAT No: CL-TDA-NO-06
CAS No: NA
Mol Wt: 431.49
Mol F: C22H29N3O6
Inv. Status: Custom Synthesis
CAT No: CL-TDA-NO-07
CAS No: NA
Mol Wt: 431.49
Mol F: C22H29N3O6
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.